Advertisement

Contact force sensing for ablation of persistent atrial fibrillation: A randomized, multicenter trial

Published:October 10, 2017DOI:https://doi.org/10.1016/j.hrthm.2017.10.010

      Background

      Impact of contact force sensing (CFS) on ablation of persistent atrial fibrillation (PeAF) is unknown.

      Objective

      The purpose of the TOUCH AF (Therapeutic Outcomes Using Contact force Handling during Ablation of Persistent Atrial Fibrillation) randomized trial was to compare CFS-guided ablation to a CFS-blinded strategy.

      Methods

      Patients (n = 128) undergoing first-time ablation for persistent AF were randomized to a CFS-guided vs CFS-blinded strategy. In the CFS-guided procedure, operators visualized real-time force data. In the blinded procedure, force data were hidden. Wide antral pulmonary vein isolation plus a roof line were performed. Patients were followed at 3, 6, 9, and 12 months with clinical visit, ECG, and 48-hour Holter monitoring. The primary endpoint was cumulative radiofrequency (RF) time for all procedures. Atrial arrhythmia >30 seconds after 3 months was a recurrence.

      Results

      PeAF was continuous for 26 weeks (interquartile range [IQR] 13–52), and left atrial size was 45 ± 5 mm. Force in the CFS-blinded and CFS-guided arms was 12 g [IQR 6–20] and 14 g [IQR 9–20] (P = .10), respectively. Total RF time did not differ between CFS-guided and CFS-blinded groups (49 ± 14 min vs 50 ± 20 min, respectively; P = .70). Single procedure freedom from atrial arrhythmia was 60% in the CFS-guided arm and 63% in the CFS-blinded arm off drugs. Lesions with gaps were associated with significantly less force (11.4 g [IQR 6–19] vs 13.2 g [IQR 8–20], respectively; P = .0007) and less force-time integral (174 gs [IQR 91–330] vs 210 gs [IQR 113–388], respectively; P <.001).

      Conclusion

      CFS-guided ablation resulted in no difference to RF time or 12-month outcome. Lower force/force-time integral was associated with significantly more gaps.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Calkins H.
        • Hindricks G.
        • Cappato R.
        • et al.
        2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.
        Heart Rhythm. 2017; 14: e275-e444
        • Ganesan A.N.
        • Shipp N.J.
        • Brooks A.G.
        • Kuklik P.
        • Lau D.H.
        • Lim H.S.
        • Sullivan T.
        • Roberts-Thomson K.C.
        • Sanders P.
        Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
        J Am Heart Assoc. 2013; 2: e004549
        • Verma A.
        • Jiang C.Y.
        • Betts T.R.
        • et al.
        Approaches to catheter ablation for persistent atrial fibrillation.
        N Engl J Med. 2015; 372: 1812-1822
        • Kautzner J.
        • Neuzil P.
        • Lambert H.
        • Peichl P.
        • Petru J.
        • Cihak R.
        • Skoda J.
        • Wichterle D.
        • Wissner E.
        • Yulzari A.
        • Kuck K.H.
        EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation.
        Europace. 2015; 17: 1229-1235
        • Reddy V.Y.
        • Dukkipati S.R.
        • Neuzil P.
        • et al.
        Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study.
        Circulation. 2015; 132: 907-915
        • Ullah W.
        • McLean A.
        • Tayebjee M.H.
        • Gupta D.
        • Ginks M.R.
        • Haywood G.A.
        • O'Neill M.
        • Lambiase P.D.
        • Earley M.J.
        • Schilling R.J.
        Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data.
        Heart Rhythm. 2016; 13: 1761-1767
        • Kimura M.
        • Sasaki S.
        • Owada S.
        • Horiuchi D.
        • Sasaki K.
        • Itoh T.
        • Ishida Y.
        • Kinjo T.
        • Tomita H.
        • Okumura K.
        Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study.
        Heart Rhythm. 2014; 11: 984-991
        • Shurrab M.
        • Di Biase L.
        • Briceno D.F.
        • Kaoutskaia A.
        • Haj-Yahia S.
        • Newman D.
        • Lashevsky I.
        • Nakagawa H.
        • Crystal E.
        Impact of contact force technology on atrial fibrillation ablation: a meta-analysis.
        J Am Heart Assoc. 2015; 4: e002476
        • Reddy V.Y.
        • Shah D.
        • Kautzner J.
        • et al.
        The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study.
        Heart Rhythm. 2012; 9: 1789-1795
        • Chikata A.
        • Kato T.
        • Sakagami S.
        • Kato C.
        • Saeki T.
        • Kawai K.
        • Takashima S.
        • Murai H.
        • Usui S.
        • Furusho H.
        • Kaneko S.
        • Takamura M.
        Optimal force-time integral for pulmonary vein isolation according to anatomical wall thickness under the ablation line.
        J Am Heart Assoc. 2016; 5: e003155
        • Alipour P.
        • Khaykin Y.
        • Azizi Z.
        • Pirbaglou M.
        • Conti S.
        • Ritvo P.
        • Pantano A.
        • Verma A.
        Determination of the ideal contact force required during pulmonary vein antrum isolation (abstract).
        J Am Coll Cardiol. 2017; 69: 402
        • Gitenay E.
        • O' Hara G.E.
        • Sarrazin J.F.
        • Nault I.
        • Philippon F.
        • Sadron Blaye-Felice M.
        • Laaouaj J.
        • Champagne J.
        Contact-force catheters: efficacy versus safety? Case report of 2 atrioesophageal fistulae.
        J Cardiovasc Electrophysiol. 2016; 27: 1483-1487
        • Natale A.
        • Reddy V.Y.
        • Monir G.
        • et al.
        Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial.
        J Am Coll Cardiol. 2014; 64: 647-656
        • Das M.
        • Loveday J.J.
        • Wynn G.J.
        • Gomes S.
        • Saeed Y.
        • Bonnett L.J.
        • Waktare J.E.
        • Todd D.M.
        • Hall M.C.
        • Snowdon R.L.
        • Modi S.
        • Gupta D.
        Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values.
        Europace. 2017; 19: 775-783
        • El Haddad M.
        • Taghji P.
        • Phlips T.
        • Wolf M.
        • Demolder A.
        • Choudhury R.
        • Knecht S.
        • Vandekerckhove Y.
        • Tavernier R.
        • Nakagawa H.
        • Duytschaever M.
        Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain.
        Circ Arrhythm Electrophysiol. 2017; 10: e004867
        • Fujiwara R.
        • Imamura K.
        • Kijima Y.
        • et al.
        The importance of catheter stability evaluated by Visitag(TM) during pulmonary vein isolation.
        J Interv Card Electrophysiol. 2016; 46: 161-166
        • Vogler J.
        • Willems S.
        • Sultan A.
        • Schreiber D.
        • Luker J.
        • Servatius H.
        • Schaffer B.
        • Moser J.
        • Hoffmann B.A.
        • Steven D.
        Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial.
        J Am Coll Cardiol. 2015; 66: 2743-2752